Similar outcomes for chemosensitive (CS) relapsed or primary refractory peripheral T-cell lymphoma (PTCL) and diffuse large B-cell lymphoma (DLBCL) treated with autologous transplantation (ASCT).

被引：0
|
作者：
Kewalramani, T [1 ]
Nimer, SD [1 ]
Zelenetz, AD [1 ]
Hamlin, PA [1 ]
Horwitz, S [1 ]
Qin, J [1 ]
Malhotra, S [1 ]
Yahalom, J [1 ]
Moskowitz, CH [1 ]
机构：
[1] MSKCC, New York, NY USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2541
引用
收藏
页码：646A / 646A
页数：1
相关论文
共 50 条
  • [1] Outcome of salvage therapy for relapsed or refractory peripheral T-cell lymphoma (PTCL), anaplastic large cell lymphoma (ALCL), and diffuse large B-cell lymphoma (DLBCL).
    Wu, G.
    Kuruvilla, J.
    Nagy, T.
    Keating, A.
    Crump, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 348S - 348S
  • [2] Peripheral T-cell lymphoma (PTCL): A clinicopathologic analysis with comparison to diffuse large B-cell lymphoma (DLBCL)
    Weisenburger, DD
    Aoun, P
    Greiner, TC
    Chan, WC
    Smith, LM
    Bociek, RG
    Bierman, PJ
    Vose, JM
    Armitage, JO
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 256A - 256A
  • [3] Peripheral T-cell lymphoma (PTCL): A clinicopathologic analysis with comparison to diffuse large B-cell lymphoma (DLBCL)
    Weisenburger, DD
    Aoun, P
    Greiner, TC
    Chan, WC
    Smith, LM
    Bociek, RG
    Bierman, PJ
    Vase, JM
    Armitage, JO
    [J]. MODERN PATHOLOGY, 2005, 18 : 256A - 256A
  • [4] Effect of rituximab (R) on clinical outcomes after autologous stem cell transplantation (ASCT) in pts with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
    Adegbola, O.
    Andreadis, C.
    Schuster, S. J.
    Chong, E. A.
    Nasta, S. D.
    Porter, D. L.
    Luger, S. M.
    Tsai, D. E.
    Cunningham, K.
    Stadtmauer, E. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma
    Kewalramani, Tarun
    Zelenetz, Andrew D.
    Teruya-Feldstein, Julie
    Hamlin, Paul
    Yahalom, Joachim
    Horwitz, Steven
    Nimer, Stephen D.
    Moskowitz, Craig H.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (02) : 202 - 207
  • [6] Gene expression profiling of peripheral T-cell lymphoma (PTCL, NOS) and comparison to diffuse large B-cell lymphoma (DLBCL).
    Mahadevan, D
    Spier, C
    Croce, KD
    Miller, S
    George, B
    Riley, CJ
    Warner, S
    Grogan, TM
    Miller, TP
    [J]. BLOOD, 2004, 104 (11) : 627A - 627A
  • [7] Phase II multi-center study of ruxolitinib phosphate for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and peripheral T-cell lymphoma (PTCL).
    Kallam, Avyakta
    Witzig, Thomas E.
    Roschewski, Mark J.
    Lyden, Elizabeth
    Lunning, Matthew Alexander
    Bierman, Philip Jay
    Bociek, Gregory
    Armitage, James O.
    Vose, Julie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Outcomes of salvage chemotherapy and autologous stem cell transplantation for relapsed or refractory primary mediastinal large B cell lymphoma (PMLCL) are inferior to diffuse large B cell lymphoma (DLBCL).
    Kuruvilla, J
    Nagy, T
    Pintilie, M
    Keating, A
    Crump, M
    [J]. BLOOD, 2005, 106 (11) : 590A - 590A
  • [9] Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?
    Struessmann, Tim
    Marks, Reinhard
    Waesch, Ralph
    [J]. CANCERS, 2024, 16 (11)
  • [10] Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma
    Kuruvilla, John
    Pintilie, Melania
    Tsang, Richard
    Nagy, Tracy
    Keating, Armand
    Crump, Michael
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (07) : 1329 - 1336
12345